98 related articles for article (PubMed ID: 1088166)
1. Therapeutic trials with levamisole and other agents in NZB/W mice.
Russell AS
J Rheumatol; 1976 Dec; 3(4):380-3. PubMed ID: 1088166
[TBL] [Abstract][Full Text] [Related]
2. Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.
Zulman J; Michalski J; McCombs C; Greenspan J; Talal N
Clin Exp Immunol; 1978 Feb; 31(2):321-7. PubMed ID: 306328
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
4. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
[TBL] [Abstract][Full Text] [Related]
5. Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
Austin HA; Patel AD; Cadena CA; Boumpas DT; Balow JE
J Rheumatol; 1997 Jan; 24(1):61-8. PubMed ID: 9002012
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
7. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H
Lupus; 2007; 16(5):335-41. PubMed ID: 17576735
[TBL] [Abstract][Full Text] [Related]
8. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.
Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T
Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582
[TBL] [Abstract][Full Text] [Related]
9. [The effect of levamisole on spontaneous autoimmune disease in NZB/W mice].
Rovenský J; Korcáková L; Zitnan D; Pekárek J; Svejcar J
Fysiatr Revmatol Vestn; 1982 Apr; 60(2):86-90. PubMed ID: 7201450
[No Abstract] [Full Text] [Related]
10. Ribavirin: efficacy in the treatment of murine autoimmune disease.
Klassen LW; Budman DR; Williams GW; Steinberg AD; Gerber NL
Science; 1977 Feb; 195(4280):787-9. PubMed ID: 299957
[TBL] [Abstract][Full Text] [Related]
11. The New Zealand mouse as a model for the therapy of human SLE: immunomodulation of murine lupus by sex hormones and cyclophosphamide.
Papoian R; Roubinian JR; Dauphinée MJ; Talal N
Agents Actions Suppl; 1980; 7():41-5. PubMed ID: 6941685
[No Abstract] [Full Text] [Related]
12. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
Dong L; Ito S; Ishii KJ; Klinman DM
Arthritis Rheum; 2005 Feb; 52(2):651-8. PubMed ID: 15692999
[TBL] [Abstract][Full Text] [Related]
13. Levamisole in systemic lupus erythematosus.
Ogawa K; Sano T; Hisano G; Tsubura E
Ann Allergy; 1979 Sep; 43(3):187-9. PubMed ID: 314248
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide treatment of mouse systemic lupus erythematosus.
Horowitz RE; Dubois EL; Weiner J; Strain L
Lab Invest; 1969 Sep; 21(3):199-206. PubMed ID: 4185855
[No Abstract] [Full Text] [Related]
15. Effect of ultraviolet light on disease characteristics of NZB/W mice.
Davis P; Percy JS
J Rheumatol; 1978; 5(2):125-8. PubMed ID: 307606
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
Gunn HC
Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
[TBL] [Abstract][Full Text] [Related]
17. Effect of the B cell superantigen protein A from S. aureus on the early lupus disease of (NZBxNZW) F1 mice.
Viau M; Zouali M
Mol Immunol; 2005 May; 42(7):849-55. PubMed ID: 15829273
[TBL] [Abstract][Full Text] [Related]
18. Clonality of the spontaneous immune response to DNA in murine lupus.
Cavallo T; Granholm NA; Graves K; Izui S
J Clin Lab Immunol; 1986 Jun; 20(2):81-7. PubMed ID: 3488408
[TBL] [Abstract][Full Text] [Related]
19. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis.
Shiraki M; Fujiwara M; Tomura S
Clin Exp Immunol; 1984 Feb; 55(2):333-9. PubMed ID: 6607792
[TBL] [Abstract][Full Text] [Related]
20. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
Sato MN; Minoprio P; Avrameas S; Ternynck T
Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
